Results 1 to 10 of about 337,805 (310)
Renal biopsy in diabetic patients: Histopathological and clinical correlations [PDF]
Revista Portuguesa de Nefrologia e Hipertensão, 2021 Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diabetic renal disease is suspected, such as in the presence of a rapid ...
Joana Paixão +10 more
doaj +1 more source
Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes [PDF]
, 2013 Background: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease.
A Krupa +67 more
core +14 more sources
Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
Frontiers in Endocrinology, 2023 BackgroundObesity often initiates or coexists with metabolic abnormalities. This study aimed to investigate the pathological characteristics and the independent or mutual relations of obesity and metabolic abnormalities with end-stage kidney disease ...
Lijun Zhao +12 more
doaj +1 more source
Research progress of single nucleotide polymorphisms and immune cells in diabetic kidney disease [PDF]
Jichu yixue yu linchuang, 2022 Diabetic kidney disease has obvious family aggregation and ethnic differences, some single nucleotide polymorphisms (SNPs) related to the susceptibility of diabetic kidney disease have been identified, especially engulfment and cell motility 1 (ELMO1 ...
GUO Meng-ran, MIN Hang, YE Yue, XU Xiao-shuang, ZHEN Dong-hu
doaj +1 more source
Frontiers in Pharmacology, 2022 Purpose: This study aimed to investigate the effects of intravitreal (IVT) VEGFi on long-term renal outcomes in patients with biopsy-proven diabetic kidney disease (DKD).Patients and methods: Patients prescribed IVT VEGFi (VEGFi group) were enrolled from
Xiang Xiao +19 more
doaj +1 more source
Frontiers in Endocrinology, 2022 AimsAbnormalities of glucolipid metabolism are critical mechanisms involved in the progression of diabetic kidney disease (DKD). Bile acids have an essential role in regulating glucolipid metabolism.
Xiang Xiao +18 more
doaj +1 more source
Exploring molecular targets in diabetic kidney disease [PDF]
Kidney Research and Clinical Practice, 2022 Diabetic kidney disease is the leading cause of end-stage kidney disease, and it remains a major challenge. Many factors, such as glomerular hyperfiltration, oxidative stress, inflammation, hypoxia, and epigenetics, are associated with the progression of
Sayako Maruno +2 more
doaj +1 more source
Endocrine Connections, 2021 Objective: To investigate the relationship between serum uric acid (SUA) level and renal outcome in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN). Methods: A total of 393 Chinese patients with T2DM and biopsy-proven DN and
Yutong Zou +16 more
doaj +1 more source
New Diabetes Therapies and Diabetic Kidney Disease Progression:the Role of SGLT-2 Inhibitors [PDF]
, 2018 Purpose of Review Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have emerged as a promising drug class for the treatment of diabetic kidney disease.
Dekkers, Claire C. J. +2 more
core +5 more sources
Renal Failure, 2022 We aimed to determine the utility of biopsy data and anemia for the prediction of renal outcomes in Chinese patients with type 2 diabetes. In total, 441 Chinese patients with type 2 diabetes and biopsy-confirmed diabetic nephropathy (DN) were enrolled in
Lijun Zhao +16 more
doaj +1 more source